Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_assertion type Assertion NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_head.
- NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_assertion description "[However, while EphA2 has been reported to enhance tumorigenesis, proliferation, and MAPK activation in several model systems, other studies suggest that EphA2 activation diminishes these processes and inhibits the activity of MAPK upon ligand stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_provenance.
- NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_assertion evidence source_evidence_literature NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_provenance.
- NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_assertion SIO_000772 18079969 NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_provenance.
- NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_assertion wasDerivedFrom befree-20150227 NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_provenance.
- NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_assertion wasGeneratedBy ECO_0000203 NP371749.RAvpUFp4H9R4V4iYwwAg4uqBFd7mQxz-1QVgJNqYpT5kE130_provenance.